- Home
- OSPN vs PRME Comparison
OSPN vs PRME Comparison
Compare OSPN & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSPN
- PRME
- Stock Information
- Founded
- OSPN 1991
- PRME 2019
- Country
- OSPN United States
- PRME United States
- Employees
- OSPN N/A
- PRME N/A
- Industry
- OSPN EDP Services
- PRME Medicinal Chemicals and Botanical Products
- Sector
- OSPN Technology
- PRME Health Care
- Exchange
- OSPN Nasdaq
- PRME Nasdaq
- Market Cap
- OSPN 668.7M
- PRME 624.0M
- IPO Year
- OSPN 1998
- PRME 2022
- Fundamental
- Price
- OSPN $14.56
- PRME $3.55
- Analyst Decision
- OSPN Strong Buy
- PRME Buy
- Analyst Count
- OSPN 2
- PRME 6
- Target Price
- OSPN $18.00
- PRME $8.88
- AVG Volume (30 Days)
- OSPN 448.8K
- PRME 4.0M
- Earning Date
- OSPN 08-05-2025
- PRME 08-07-2025
- Dividend Yield
- OSPN 3.30%
- PRME N/A
- EPS Growth
- OSPN 265.73
- PRME N/A
- EPS
- OSPN 1.53
- PRME N/A
- Revenue
- OSPN $240,621,000.00
- PRME $4,961,000.00
- Revenue This Year
- OSPN $4.23
- PRME $126.92
- Revenue Next Year
- OSPN $5.09
- PRME $87.32
- P/E Ratio
- OSPN $9.53
- PRME N/A
- Revenue Growth
- OSPN N/A
- PRME 739.42
- 52 Week Low
- OSPN $12.51
- PRME $1.11
- 52 Week High
- OSPN $20.37
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- OSPN 52.22
- PRME 48.57
- Support Level
- OSPN $13.68
- PRME $3.09
- Resistance Level
- OSPN $14.16
- PRME $3.88
- Average True Range (ATR)
- OSPN 0.51
- PRME 0.31
- MACD
- OSPN 0.14
- PRME -0.09
- Stochastic Oscillator
- OSPN 91.11
- PRME 32.96
About OSPN OneSpan Inc.
OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.